SAN DIEGO, April 20, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company") today announced it awarded inducement grants on April 20, 2026 under the Company's 2026 Employment Inducement Incentive Award Plan (the "2026 Inducement Plan") as a material inducement to the...
Hence then, the article about atrium therapeutics announces inducement grants under nasdaq listing rule 5635 c 4 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) )
Also on site :
- Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596
- Mayor Zohran Mamdani Refuses Jimmy Kimmel’s Request to Text Trump a Selfie of Them
- 1972 Soft Rock Classic, Inspired by a Soldier’s Harrowing Story, Became One of America’s Biggest Hits